CBL and acute myeloid leukemia: Here, we expand on our previous findings to show that, because of the similarities between FLT3 signalling in mutant FLT3‐ and mutant CBL‐expressing AML, the inhibitory effects of FLT3 inhibitors can similarly be potentiated by SYK inhibition in both AML subtypes.